Adaptimmune Therapeutics
ADAP
#9324
Rank
S$89.32 M
Marketcap
$0.35
Share price
-20.31%
Change (1 day)
-81.22%
Change (1 year)

Earnings for Adaptimmune Therapeutics (ADAP)

Earnings in 2024 (TTM): -S$87.06 Million

According to Adaptimmune Therapeutics's latest financial reports the company's current earnings are S$0.17 Billion. , an increase over its 2023 earnings that were of -S$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Adaptimmune Therapeutics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 -S$87.7 Million-41.87%
2023 -S$0.16 Billion-30.65%
2022 -S$0.22 Billion-0.36%
2021 -S$0.22 Billion21.62%
2020 -S$0.18 Billion-4.55%
2019 -S$0.19 Billion69%
2018 -S$0.12 Billion-7.47%
2017 -S$0.13 Billion24.71%
2016 -S$96.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.22 Billion 140.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$10.23 Million-88.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.34 Billion 286.58%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
S$0.91 B-1,145.88%๐Ÿ‡บ๐Ÿ‡ธ USA